Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol

References

• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329731517717971
   PubMed Web of Science ®Google Scholar
• MaradanaMRYekolluSKZengBImmunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitisMetabolism201878809410.1016/j.metabol.2017.09.00228941597
   PubMed Web of Science ®Google Scholar
• El-SherbinyMEldosokyMEl-ShafeyMVitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat dietChem Biol Interact2018288657510.1016/j.cbi.2018.04.01029653100
   PubMedGoogle Scholar
• TackeFTargeting hepatic macrophages to treat liver diseasesJ Hepatol20176661300131228267621
   PubMed Web of Science ®Google Scholar
• SvendsenPGraversenJHEtzerodtAAntibody-directed glucocorticoid targeting to CD163 in M2-type macrophages attenuates fructose-induced liver inflammatory changesMol Ther Methods Clin Dev20174506128344991
   PubMedGoogle Scholar
• NardinALefebvreMLLabroquereKFaureOAbastadoJPLiposomal muramyl tripeptide phosphatidylethanolamine: targeting and activating macrophages for adjuvant treatment of osteosarcomaCurr Cancer Drug Targets20066212313316529542
   PubMed Web of Science ®Google Scholar
• NeveACorradoACantatoreFPImmunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritisClin Exp Med201414327528323824148
   PubMedGoogle Scholar
• TackeFZimmermannHWMacrophage heterogeneity in liver injury and fibrosisJ Hepatol20146051090109624412603
   PubMed Web of Science ®Google Scholar
• Schmidt-ArrasDRose-JohnSIL-6 pathway in the liver: from physiopathology to therapyJ Hepatol20166461403141526867490
   PubMed Web of Science ®Google Scholar
• BeilfussJBergVSneveMJordeRKamychevaEEffects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjectsCytokine201260387087410.1016/j.cyto.2012.07.03222925537
   PubMed Web of Science ®Google Scholar
• GiuliettiAvan EttenEOverberghLStoffelsKBouillonRMathieuCMonocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-dihydroxyvitamin D(3) works as anti-inflammatoryDiabetes Res Clin Pract2007771475710.1016/j.diabres.2006.10.00717112620
   PubMed Web of Science ®Google Scholar
• BeyerMMallmannMRXueJHigh-resolution transcriptome of human macrophagesPLoS One201279e4546610.1371/journal.pone.004546623029029
   PubMedGoogle Scholar
• MillsCDThomasACLenzLLMunderMMacrophage: SHIP of immunityFront Immunol2014562010.3389/fimmu.2014.0062025538705
   PubMedGoogle Scholar
• EtzerodtAMoestrupSKCD163 and inflammation: biological, diagnostic, and therapeutic aspectsAntioxid Redox Signal201318172352236310.1089/ars.2012.483422900885
   PubMedGoogle Scholar
• EtzerodtAKjolbyMNielsenMJManieckiMSvendsenPMoestrupSKPlasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruptionAntioxid Redox Signal201318172254226310.1089/ars.2012.460522793784
   PubMedGoogle Scholar
• OmatsuMKunimuraTMikogamiTDifference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumorsDiagn Pathol2014921510.1186/s13000-014-0215-725499804
   PubMedGoogle Scholar
• Di RosaMMalaguarneraGDe GregorioCPalumboMNunnariGMalaguarneraLImmuno-modulatory effects of vitamin D3 in human monocyte and macrophagesCell Immunol20122801364310.1016/j.cellimm.2012.10.00923261827
   PubMed Web of Science ®Google Scholar
• Sylvia ChristakosPDVerstuyfAVerlindenLCarmelietGVitamin D: metabolism, molecular mechanism of action and pleiotropic effectsPhysiol Rev201696136540826681795
   PubMedGoogle Scholar
• VanherwegenASGysemansCMathieuCVitamin D endocrinology on the cross-road between immunity and metabolismMol Cell Endocrinol2017453526710.1016/j.mce.2017.04.01828461074
   PubMed Web of Science ®Google Scholar
• HewisonMFreemanLHughesSVDifferential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cellsJ Immunol2003170115382539012759412
   PubMed Web of Science ®Google Scholar
• VeldmanCMCantornaMTDeLucaHFExpression of 1,25-dihy-droxyvitamin D(3) receptor in the immune systemArch Biochem Biophys2000374233433810.1006/abbi.1999.160510666315
   PubMed Web of Science ®Google Scholar
• ChenSSimsGPChenXXGuYYChenSLipskyPEModulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiationJ Immunol200717931634164717641030
   PubMed Web of Science ®Google Scholar
• JefferyLEWoodAMQureshiOSAvailability of 25-hydroxyvi-tamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responsesJ Immunol2012189115155516410.4049/jimmunol.120078623087405
   PubMed Web of Science ®Google Scholar
• GarbossaSGFolliFVitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolismRev Endocr Metab Disord20171824325810.1007/s11154-017-9423-228409320
   PubMed Web of Science ®Google Scholar
• BesslerHDjaldettiM1alpha,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cellsBiomed Pharmacother201266642843210.1016/j.biopha.2012.06.00522795808
   PubMedGoogle Scholar
• SmithDCJohnsonCSFreemanCCMuindiJWilsonJWTrumpDLA Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancyClin Cancer Res1999561339134510389917
   PubMed Web of Science ®Google Scholar
• DeebKKTrumpDLJohnsonCSVitamin D signalling pathways in cancer: potential for anticancer therapeuticsNat Rev Cancer20077968470010.1038/nrc219617721433
   PubMed Web of Science ®Google Scholar
• ChenYLiuWSunT1,25-dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophagesJ Immunol201319073687369510.4049/jimmunol.120327323436936
   PubMed Web of Science ®Google Scholar
• ChenYZhangJGeXDuJDebDKLiYCVitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta proteinJ Biol Chem201328827194501945810.1074/jbc.M113.46767023671281
   PubMed Web of Science ®Google Scholar
• HanXLiLYangJKingGXiaoZQuarlesLDCounter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophagesFEBS Lett20165901536710.1002/1873-3468.1204026762170
   PubMed Web of Science ®Google Scholar
• LiuCShaurovaTShoemakerSPetkovichMHershbergerPAWuYTumor-targeted nanoparticles deliver a vitamin D-based drug payload for the treatment of EGFR tyrosine kinase inhibitor-resistant lung cancerMol Pharm20185832163226
   Google Scholar
• ZhigaltsevIVBelliveauNHafezIBottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixingLangmuir20122873633364022268499
   PubMed Web of Science ®Google Scholar
• UlbrichWLamprechtATargeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseasesJ R Soc Interface20107Suppl 1S55S6619940000
   PubMed Web of Science ®Google Scholar
• AlaargAJordanNYVerhoefJJMetselaarJMStormGKokRJDocosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessmentInt J Nanomedicine2016115027504027785012
   PubMed Web of Science ®Google Scholar
• EtzerodtAManieckiMBGraversenJHMollerHJTorchilinVPMoestrupSKEfficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163J Control Release20121601728022306335
   PubMed Web of Science ®Google Scholar
• MadsenMMollerHJNielsenMJMolecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain regionJ Biol Chem200427949515615156715448162
   PubMed Web of Science ®Google Scholar
• TorchilinVPLevchenkoTSLukyanovANp-Nitrophenyl-carbonyl-PEG-PE-liposomes: fast and simple attachment of speci¢c ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groupsBiochim Biophys Acta20011511200139741111286983
   PubMedGoogle Scholar
• Marques-GallegoPde KroonAILigation strategies for targeting liposomal nanocarriersBiomed Res Int2014201412945825126543
   PubMed Web of Science ®Google Scholar
• VandoorenJBornBSolomonovICircular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1Biochem J2015465225927025360794
   PubMedGoogle Scholar
• AndersenCLJensenJLOrntoftTFNormalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data setsCancer Res200464155245525015289330
   PubMed Web of Science ®Google Scholar
• JainABarveAZhaoZJinWChengKComparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA deliveryMol Pharm20171451517152728026957
   PubMedGoogle Scholar
• DongYDTchungENowellCMicrofluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetrationJ Liposome Res20172911929020849
   PubMedGoogle Scholar
• GranfeldtAHvasCLGraversenJHTargeting dexamethasone to macrophages in a porcine endotoxemic modelCrit Care Med20134111e309e31823928834
   PubMed Web of Science ®Google Scholar
• GraversenJHSvendsenPDagnaes-HansenFTargeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasoneMol Ther20122081550155822643864
   PubMed Web of Science ®Google Scholar
• RamalhoMJLoureiroJAGomesBFrascoMFCoelhoMAPereiraMCPLGA nanoparticles as a platform for vitamin D-based cancer therapyBeilstein J Nanotechnol201561306131826199834
   PubMed Web of Science ®Google Scholar
• LameijerMATangJNahrendorfMBeelenRHMulderWJMonocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of diseaseExpert Rev Mol Diagn201313656758023895127
   PubMed Web of Science ®Google Scholar
• JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
   PubMed Web of Science ®Google Scholar
• WynnTAChawlaAPollardJWMacrophage biology in development, homeostasis and diseaseNature2013496744644545523619691
   PubMed Web of Science ®Google Scholar
• MurrayPJWynnTAProtective and pathogenic functions of macrophage subsetsNat Rev Immunol2011111172373721997792
   PubMed Web of Science ®Google Scholar
• KristiansenMGraversenJHJacobsenCIdentification of the haemoglobin scavenger receptorNature2001409681719820111196644
   PubMed Web of Science ®Google Scholar
• SanseverinoIRinaldiAOPurificatoCCCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patientsJ Steroid Biochem Mol Biol2014144Pt A10210524184699
   PubMedGoogle Scholar
• WangYCHsiehCCKuoHFEffect of vitamin D3 on monocyte chemoattractant protein 1 production in monocytes and macrophagesActa Cardiol Sin201430214415027122781
   PubMedGoogle Scholar
• TokudaNMizukiNKasaharaMLevyRB1,25-dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytesImmunology19927523493541551697
   PubMedGoogle Scholar
• RigbyWFWaughMGrazianoRFRegulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3Blood19907611891972364169
   PubMedGoogle Scholar
• AlmerighiCSinistroACavazzaACiapriniCRocchiGBergaminiA1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytesCytokine200945319019719186073
   PubMedGoogle Scholar
• HeineGNiesnerUChangHD1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cellsEur J Immunol20083882210221818651709
   PubMed Web of Science ®Google Scholar
• PennaGAdoriniL1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activationJ Immunol200016452405241110679076
   PubMed Web of Science ®Google Scholar
• SercombeLVeeratiTMoheimaniFWuSYSoodAKHuaSAdvances and challenges of liposome assisted drug deliveryFront Pharmacol2015628626648870
   PubMed Web of Science ®Google Scholar
• KraftJCFreelingJPWangZHoRJEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsJ Pharm Sci20141031295224338748
   PubMed Web of Science ®Google Scholar
• MoghimiSMMoghimiMEnhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregationBiochim Biophys Acta200817781515517936719
   PubMedGoogle Scholar
• PridgenEMAlexisFKuoTTTransepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral deliverySci Transl Med20135213213ra167
   PubMed Web of Science ®Google Scholar